“Oral versus intravenous high-dose methylprednisolone for treatment of relapses in patients with multiple sclerosis (COPOUSEP): a randomised, controlled, double-blind, non-inferiority trial.”

frothmouthfrothmouth のブックマーク 2015/07/14 10:53

その他

このブックマークにはスターがありません。
最初のスターをつけてみよう!

Oral versus intravenous high-dose methylprednisolone for treatment of relapses in patients with multiple sclerosis (COPOUSEP): a randomised, controlled, double-blind, non-inferiority trial - PubMed

    The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site. The site is secure. The htt...

    \ コメントが サクサク読める アプリです /

    • App Storeからダウンロード
    • Google Playで手に入れよう